1283432

Tae Min Kim, M.D., Ph.D. — FEI 3028696324

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 29, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Seoul (Korea (the Republic of))

Additional Details

Clinical Investigator (CI)